Hitomi Jo

Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab

Hitomi Jo, Tatsuya Yoshida, Hidehito Horinouchi et al. · Cancer Immunology Immunotherapy · 2021 · 35 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic Alterations

Hitomi Jo, Shigehiro Yagishita, Yoshiharu Hayashi et al. · Molecular Cancer Therapeutics · 2021 · 17 citations · Full text

Medicine, Oncology, Pharmacology +16

Correlation between body mass index and efficacy of anti-PD-1 inhibitor in patients with non-small cell lung cancer

Akiko Tateishi, Hidehito Horinouchi, Tatsuya Yoshida et al. · Respiratory Investigation · 2021 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients

Mayu Ohuchi, Shigehiro Yagishita, Hitomi Jo et al. · Lung Cancer · 2022 · 12 citations

Pharmacy, Oncology, Pharmacokinetics +16